Compare
Compare Drug Products
Pharmacies sometimes switch which manufacturer's version of a drug they stock. Enter both product names or DINs — usually printed right on the label or bottle — to see how they compare.
First product
vsCIPROFLOXACIN INTRAVENOUS INFUSION BP
Second product
ACT CIPROFLOXACIN
This comparison shows regulatory facts from Health Canada. It does not determine whether these products are interchangeable — ask your pharmacist before switching.
↔ Swipe to see both products
| CIPROFLOXACIN INTRAVENOUS INFUSION BP | ACT CIPROFLOXACIN | |
|---|---|---|
| Manufacturer | SANDOZ CANADA INCORPORATED | TEVA CANADA LIMITED |
| Active ingredient | CIPROFLOXACIN | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) |
| Strength | 2MG | 250MG |
| Dosage form | SOLUTION | Tablet |
| Route | INTRAVENOUS | Oral |
| Health Canada status | Marketed | Marketed |
| Shortage status | No current shortage | No current shortage |
| Recall / safety alert | None on file | None on file |
Different active ingredientDifferent strengthDifferent dosage formDifferent route